| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |